Plasma Protein Therapeutics Association (PPTA)
25th ISICEM
25th International Congress on Intensive Care and Emergency Medicine
From 21-Mar-05 to 25-Mar-05, Brussels
The International Symposium on Intensive Care and Emergency Medicine is organised by the department of Intensive Care Emergency Medicine of Erasme Hospital, Free University of Brussels, in association with the Belgian Society of Intensive Care and Emergency Medicine (SIZ). The meeting is held every year in March, in Brussels and this year we will celebrate its 25th anniversary. Started in 1980, this meeting has become established as one of the largest in its field, now attracting more than 4700 participants from countries world-wide.
Read more...
 
[Molecular adsorption in liver failure]
[Article in Italian]
Ital Nefrol.
2005 Jan-Feb;22 Suppl 31:S156-60

Marangoni R.

U.O. di Epatologia, Ospedale S. Giuseppe, Milano - Italy. franca.marangoni@unimi.it

The molecular adsorbent recirculating system (MARS) method removes from the blood catabolites either free in the plasma water such as uremic toxins and ammonia, taking advantage of dialysis or free albumin bound ones, like hepatic toxins, transferring them from the albumin in the blood to the albumin circulating in a closed loop where toxins are removed by adsorbtion on resins (charcoal and ion exchange resin). 
Read more...
 
Progress in treatment of massive ascites and hepatorenal syndrome.
Progress in treatment of massive ascites and hepatorenal syndrome.

Gerbes AL, Gulberg V.
World J Gastroenterol. 2006 Jan 28;12(4):516-519.

Department of Medicine II, Klinikum of the University of Munich-Grosshadern, Marchioninistr. 15, 81377 Munich, Germany. This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Massive ascites and hepatorenal syndrome (HRS) are frequent complications of liver cirrhosis. Thus, effective therapy is of great clinical importance. This concise review provides an update of recent advances and new developments. Therapeutic paracentesis can be safely performed even in patients with severe coagulopathy.
Read more...
 
Conflicting clinical trial data: a lesson from albumin.
Conflicting clinical trial data: a lesson from albumin.

Martin G
Crit care 2005;9(6):649-50. Epub 2005 Nov 22

Assistant Professor of Medicine, Division of Pulmonary, Allergy and Critical Care, Emory University School of Medicine, Atlanta, Georgia, USA. This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

ABSTRACT : Albumin is a frequently prescribed drug in hospitalized patients, and its effect on clinical outcomes has been scrutinized in recent years.
Read more...
 
Plasma volume expansion of 5% albumin, 4% gelatin, 6% HES 130/0.4, and normal saline under increased

Plasma volume expansion of 5% albumin, 4% gelatin, 6% HES 130/0.4, and normal saline under increased microvascular permeability in the rat.

Intensive Care Med. 2006 Nov 21;

Dubniks M, Persson J, Grande PO.

Department of Anesthesiology and Intensive Care, Lund University Hospital, 22185, Lund, Sweden, This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

OBJECTIVE: To compare the colloids 5% albumin, 4% gelatin, and 6% HES 130/0.4 with one another and with normal saline regarding their plasma expanding effects at increased permeability and to compare the results with those from a previous study at normal permeability. DESIGN AND SETTING: Prospective controlled randomized laboratory study in a university research laboratory. SUBJECTS: 48 adult male Sprague-Dawley rats.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 20